Fingerprint
Dive into the research topics of 'Therapeutic benefits of Ipilimumab among Japanese patients with Nivolumab-refractory mucosal melanoma: A case series study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Therapeutic benefits of Ipilimumab among Japanese patients with Nivolumab-refractory mucosal melanoma: A case series study
Ken Saijo, Hiroo Imai, Kota Ouchi, Yoshinari Okada, Yuko Sato, Keigo Komine, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka
Research output: Contribution to journal › Article › peer-review
2
Citations
(Scopus)